On a day-to-day basis, Kenneth Nyblom is the CEO of FGL (The Association for Generic Medicines and Biosimilars). Recently he was also appointed chairman of the board at e-VIS and as such will lead the organisation’s operations. But he is not new to the context, but has been involved since the planning phase.
Publicity photo: FGL